{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T11:40:02Z","timestamp":1739101202856,"version":"3.37.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"17-18","license":[{"start":{"date-parts":[[2003,9,1]],"date-time":"2003-09-01T00:00:00Z","timestamp":1062374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,9,1]],"date-time":"2003-09-01T00:00:00Z","timestamp":1062374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2003,9]]},"DOI":"10.1007\/bf03040468","type":"journal-article","created":{"date-parts":[[2009,5,12]],"date-time":"2009-05-12T18:09:10Z","timestamp":1242151750000},"source":"Crossref","is-referenced-by-count":2,"title":["Sympathische \u00dcberaktivit\u00e4t und Niere","Sympathetic overactivity and the kidney"],"prefix":"10.1007","volume":"115","author":[{"given":"Antje","family":"Habicht","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Watschinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF03040468_CR1","doi-asserted-by":"publisher","first-page":"112S","DOI":"10.1016\/S0895-7061(00)00228-4","volume":"13","author":"RD Brook","year":"2000","unstructured":"Brook RD, Julius S (2000) Autonomic imbalance, hypertension, and cardiovascular risk. Am J Hypertens 13: 112S-122S","journal-title":"Am J Hypertens"},{"key":"BF03040468_CR2","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/01.HYP.34.4.724","volume":"34","author":"G Mancia","year":"1999","unstructured":"Mancia G, Grassi G, Giannattasio C, Seravalle G (1999) Sympathetic activation in the pathogenesis of hypertension and progression of organ damage. Hypertension 34: 724\u2013728","journal-title":"Hypertension"},{"key":"BF03040468_CR3","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1161\/01.HYP.0000047205.52509.8A","volume":"41","author":"GF DiBona","year":"2003","unstructured":"DiBona GF (2003) Neural control of the kidney: past, present, and future. Hypertension 41: 621\u2013624","journal-title":"Hypertension"},{"key":"BF03040468_CR4","first-page":"561","volume-title":"Handbook of the autonomic nervous system in health and disease","author":"LC Rump","year":"2003","unstructured":"Rump LC, Amann K, Ritz E (2003) Sympathetic innervation of the kidney in health and disease. In: Bolis L, Licinio J, Govoni S (eds) Handbook of the autonomic nervous system in health and disease. Marcel Dekker: New York Basel, pp 561\u2013587"},{"key":"BF03040468_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJM199601043340103","volume":"334","author":"MJ Klag","year":"1996","unstructured":"Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE, et al (1996) Blood pressure and end-stage renal disease in men. N Engl J Med 334: 13\u201318","journal-title":"N Engl J Med"},{"key":"BF03040468_CR6","doi-asserted-by":"publisher","first-page":"99S","DOI":"10.1016\/S0895-7061(00)00225-9","volume":"13","author":"M Esler","year":"2000","unstructured":"Esler M (2000) The sympathetic system and hypertension. Am J Hypertens 13: 99S-105S","journal-title":"Am J Hypertens"},{"key":"BF03040468_CR7","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1681\/ASN.V1181469","volume":"11","author":"K Amann","year":"2000","unstructured":"Amann K, Rump LC, Simonaviciene A, Oberhauser V, Wessels S, Orth SR, et al (2000) Effects of low dose sympathetic inhibition on glomerulosclerosis and albuminuria in subtotally nephrectomized rats. J Am Soc Nephrol 11: 1469\u20131478","journal-title":"J Am Soc Nephrol"},{"key":"BF03040468_CR8","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/0272-6386(95)90456-5","volume":"26","author":"VM Campese","year":"1995","unstructured":"Campese VM, Kogosov E, Koss M (1995) Renal afferent denervation prevents the progression of renal disease in the renal ablation model of chronic renal failure in the rat. Am J Kidney Dis 26: 861\u2013865","journal-title":"Am J Kidney Dis"},{"key":"BF03040468_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/00004872-200201000-00002","volume":"20","author":"RA Augustyniak","year":"2002","unstructured":"Augustyniak RA, Tuncel M, Zhang W, Toto RD, Victor RG (2002) Sympathetic overactivity as a cause of hypertension in chronic renal failure. J Hypertens 20: 3\u20139","journal-title":"J Hypertens"},{"issue":"Suppl 1","key":"BF03040468_CR10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/ndt\/16.suppl_1.67","volume":"16","author":"SR Orth","year":"2001","unstructured":"Orth SR, Amann K, Strojek K, Ritz E (2001) Sympathetic overactivity and arterial hypertension in renal failure. Nephrol Dial Transplant 16 [Suppl 1]: 67\u201369","journal-title":"Nephrol Dial Transplant"},{"key":"BF03040468_CR11","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1093\/ndt\/15.11.1735","volume":"15","author":"LC Rump","year":"2000","unstructured":"Rump LC, Amann K, Orth S, Ritz E (2000) Sympathetic overactivity in renal disease: a window to understand progression and cardiovascular complications of uraemia? Nephrol Dial Transplant 15: 1735\u20131738","journal-title":"Nephrol Dial Transplant"},{"key":"BF03040468_CR12","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/0165-1838(81)90066-7","volume":"3","author":"G Recordati","year":"1981","unstructured":"Recordati G, Moss NG, Genovesi S, Rogenes P (1981) Renal chemoreceptors. J Auton Nerv Syst 3: 237\u2013251","journal-title":"J Auton Nerv Syst"},{"key":"BF03040468_CR13","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1097\/00004872-198402040-00005","volume":"2","author":"RE Katholi","year":"1984","unstructured":"Katholi RE, Whitlow PL, Hageman GR, Woods WT (1984) Intrarenal adenosine produces hypertension by activating the sympathetic nervous system via the renal nerves in the dog. J Hypertens 2: 349\u2013359","journal-title":"J Hypertens"},{"key":"BF03040468_CR14","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1161\/01.RES.57.5.676","volume":"57","author":"JE Faber","year":"1985","unstructured":"Faber JE, Brody MJ (1985) Afferent renal nerve-dependent hypertension following acute renal artery stenosis in the conscious rat. Circ Res 57: 676\u2013688","journal-title":"Circ Res"},{"key":"BF03040468_CR15","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/ki.1986.222","volume":"30","author":"JL Cuche","year":"1986","unstructured":"Cuche JL, Prinseau J, Selz F, Ruget G, Baglin A (1986) Plasma free, sulfo- and glucuro-conjugated catecholamines in uremic patients. Kidney Int 30: 566\u2013572","journal-title":"Kidney Int"},{"key":"BF03040468_CR16","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/ki.1981.127","volume":"20","author":"VM Campese","year":"1981","unstructured":"Campese VM, Romoff MS, Levitan D, Lane K, Massry SG (1981) Mechanisms of autonomic nervous system dysfunction in uremia. Kidney Int 20: 246\u2013253","journal-title":"Kidney Int"},{"key":"BF03040468_CR17","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1056\/NEJM199904293401704","volume":"340","author":"G Ligtenberg","year":"1999","unstructured":"Ligtenberg G, Blankestijn PJ, Oey PL, Klein IH, Dijkhorst-Oei LT, Boomsma F, et al (1999) Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure. N Engl J Med 340: 1321\u20131328","journal-title":"N Engl J Med"},{"key":"BF03040468_CR18","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1056\/NEJM199212313272704","volume":"327","author":"RL Converse","year":"1992","unstructured":"Converse RL Jr., Jacobsen TN, Toto RD, Jost CM, Cosentino F, Fouad-Tarazi F, et al (1992) Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 327: 1912\u20131918","journal-title":"N Engl J Med"},{"key":"BF03040468_CR19","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1161\/01.CIR.0000034043.16664.96","volume":"106","author":"M Hausberg","year":"2002","unstructured":"Hausberg M, Kosch M, Harmelink P, Barenbrock M, Hohage H, Kisters K, et al (2002) Sympathetic nerve activity in end-stage renal disease. Circulation 106: 1974\u20131979","journal-title":"Circulation"},{"key":"BF03040468_CR20","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1681\/ASN.V991581","volume":"9","author":"HP Schobel","year":"1998","unstructured":"Schobel HP, Heusser K, Schmieder RE, Veelken R, Fischer T, Luft FC (1998) Evidence against elevated sympathetic vasoconstrictor activity in borderline hypertension. J Am Soc Nephrol 9: 1581\u20131587","journal-title":"J Am Soc Nephrol"},{"key":"BF03040468_CR21","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1161\/01.HYP.25.4.878","volume":"25","author":"VM Campese","year":"1995","unstructured":"Campese VM, Kogosov E (1995) Renal afferent denervation prevents hypertension in rats with chronic renal failure. Hypertension 25: 878\u2013882","journal-title":"Hypertension"},{"key":"BF03040468_CR22","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/ki.1997.103","volume":"51","author":"S Ye","year":"1997","unstructured":"Ye S, Ozgur B, Campese VM (1997) Renal afferent impulses, the posterior hypothalamus, and hypertension in rats with chronic renal failure. Kidney Int 51: 722\u2013727","journal-title":"Kidney Int"},{"key":"BF03040468_CR23","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3109\/10641968309048823","volume":"5","author":"F Weber","year":"1983","unstructured":"Weber F, Brodde OE, Anlauf M, Bock KD (1983) Subelassification of human beta-adrenergic receptors mediating renin release. Clin Exp Hypertens A 5: 225\u2013238","journal-title":"Clin Exp Hypertens A"},{"key":"BF03040468_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physrev.1976.56.1.1","volume":"56","author":"JO Davis","year":"1976","unstructured":"Davis JO, Freeman RH (1976) Mechanisms regulating renin release. Physiol Rev 56: 1\u201356","journal-title":"Physiol Rev"},{"key":"BF03040468_CR25","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/0165-1838(91)90086-I","volume":"34","author":"H Kannan","year":"1991","unstructured":"Kannan H, Nakamura T, Jin XJ, Hayashida Y, Yamashita H (1991) Effects of centrally administered angiotensin on sympathetic nerve activity and blood flow to the kidney in conscious rats. J Auton Nerv Syst 34: 201\u2013210","journal-title":"J Auton Nerv Syst"},{"key":"BF03040468_CR26","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1161\/01.HYP.0000018590.26853.C7","volume":"39","author":"S Ye","year":"2002","unstructured":"Ye S, Zhong H, Duong VN, Campese VM (2002) Losartan reduces central and peripheral sympathetic nerve activity in a rat model of neurogenic hypertension. Hypertension 39: 1101\u20131106","journal-title":"Hypertension"},{"key":"BF03040468_CR27","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1161\/01.HYP.0000056600.70321.C5","volume":"41","author":"ME Le Fevre","year":"2003","unstructured":"Le Fevre ME, Guild SJ, Ramchandra R, Barrett CJ, Malpas SC (2003) Role of angiotensin II in the neural control of renal function. Hypertension 41: 583\u2013591","journal-title":"Hypertension"},{"key":"BF03040468_CR28","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1161\/01.CIR.99.19.2537","volume":"99","author":"M Johansson","year":"1999","unstructured":"Johansson M, Elam M, Rundqvist B, Eisenhofer G, Herlitz H, Lambert G, et al (1999) Increased sympathetic nerve activity in renovascular hypertension. Circulation 99: 2537\u20132542","journal-title":"Circulation"},{"key":"BF03040468_CR29","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1159\/000168631","volume":"13","author":"SN Rahman","year":"1993","unstructured":"Rahman SN, Abraham WT, Van Putten VJ, Hasbargen JA, Schrier RW (1993) Increased norepinephrine secretion in patients with the nephrotic syndrome and normal glomerular filtration rates: evidence for primary sympathetic activation. Am J Nephrol 13: 266\u2013270","journal-title":"Am J Nephrol"},{"key":"BF03040468_CR30","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1159\/000013382","volume":"18","author":"G Cerasola","year":"1998","unstructured":"Cerasola G, Vecchi M, Mule G, Cottone S, Mangano MT, Andronico G, et al (1998) Sympathetic activity and blood pressure pattern in autosomal dominant polycystic kidney disease hypertensives. Am J Nephrol 18: 391\u2013398","journal-title":"Am J Nephrol"},{"key":"BF03040468_CR31","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1681\/ASN.V123602","volume":"12","author":"K Strojek","year":"2001","unstructured":"Strojek K, Grzeszczak W, Gorska J, Leschinger MI, Ritz E (2001) Lowering of microalbuminuria in diabetic patients by a sympathicoplegic agent: novel approach to prevent progression of diabetic nephropathy? J Am Soc Nephrol 12: 602\u2013605","journal-title":"J Am Soc Nephrol"},{"key":"BF03040468_CR32","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/j.1474-8673.1996.tb00056.x","volume":"16","author":"LC Rump","year":"1996","unstructured":"Rump LC, Bohmann C, Schwertfeger E, Krumme B, von Kugelgen I, Schollmeyer P (1996) Extracellular ATP in the human kidney: mode of release and vascular effects. J Auton Pharmacol 16: 371\u2013375","journal-title":"J Auton Pharmacol"},{"key":"BF03040468_CR33","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1161\/01.HYP.25.6.1224","volume":"25","author":"C Bohmann","year":"1995","unstructured":"Bohmann C, Rump LC, Schaible U, von Kugelgen I (1995) Alpha-adrenoceptor modulation of norepinephrine and ATP release in isolated kidneys of spontaneously hypertensive rats. Hypertension 25: 1224\u20131231","journal-title":"Hypertension"},{"key":"BF03040468_CR34","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1681\/ASN.V1061179","volume":"10","author":"V Oberhauser","year":"1999","unstructured":"Oberhauser V, Vonend O, Rump LC (1999) Neuropeptide Y and ATP interact to control renovascular resistance in the rat. J Am Soc Nephrol 10: 1179\u20131185","journal-title":"J Am Soc Nephrol"},{"key":"BF03040468_CR35","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1046\/j.1523-1755.2002.00315.x","volume":"61","author":"O Vonend","year":"2002","unstructured":"Vonend O, Oberhauser V, von Kugelgen I, Apel TW, Amann K, Ritz E, et al (2002) ATP release in human kidney cortex and its mitogenic effects in visceral glomerular epithelial cells. Kidney Int 61: 1617\u20131626","journal-title":"Kidney Int"},{"key":"BF03040468_CR36","doi-asserted-by":"publisher","first-page":"799","DOI":"10.2165\/00003495-199958050-00003","volume":"58","author":"P Bousquet","year":"1999","unstructured":"Bousquet P, Feldman J (1999) Drugs acting on imidazoline receptors: a review of their pharmacology, their use in blood pressure control and their potential interest in cardioprotection. Drugs 58: 799\u2013812","journal-title":"Drugs"},{"key":"BF03040468_CR37","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1046\/j.1523-1755.2001.00936.x","volume":"60","author":"K Amann","year":"2001","unstructured":"Amann K, Koch A, Hofstetter J, Gross ML, Haas C, Orth SR, et al (2001) Glomerulosclerosis and progression: effect of subantihypertensive doses of alpha and beta blockers. Kidney Int 60: 1309\u20131323","journal-title":"Kidney Int"},{"key":"BF03040468_CR38","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1046\/j.1523-1755.2002.00382.x","volume":"61","author":"G Odoni","year":"2002","unstructured":"Odoni G, Ogata H, Viedt C, Amann K, Ritz E, Orth SR (2002) Cigarette smoke condensate aggravates renal injury in the renal ablation model. Kidney Int 61: 2090\u20132098","journal-title":"Kidney Int"},{"key":"BF03040468_CR39","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1046\/j.1365-2362.1999.00566.x","volume":"29","author":"U Benck","year":"1999","unstructured":"Benck U, Clorius JH, Zuna I, Ritz E (1999) Renal hemodynamic changes during smoking: effects of adrenoreceptor blockade. Eur J Clin Invest 29: 1010\u20131018","journal-title":"Eur J Clin Invest"},{"key":"BF03040468_CR40","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1161\/01.CIR.82.5.1730","volume":"82","author":"K Swedberg","year":"1999","unstructured":"Swedberg K, Eneroth P, Kjekshus J, Wilhelmsen L (1999) Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. Circulation 82: 1730\u20131736","journal-title":"Circulation"},{"key":"BF03040468_CR41","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJM198409273111303","volume":"311","author":"JN Cohn","year":"1984","unstructured":"Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, et al (1984) Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 311: 819\u2013823","journal-title":"N Engl J Med"},{"key":"BF03040468_CR42","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1161\/01.CIR.73.4.615","volume":"73","author":"GJ Hasking","year":"1986","unstructured":"Hasking GJ, Esler MD, Jennings GL, Burton D, Johns JA, Korner PI (1986) Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation 73: 615\u2013621","journal-title":"Circulation"},{"key":"BF03040468_CR43","doi-asserted-by":"crossref","first-page":"R556","DOI":"10.1152\/ajpregu.2000.278.3.R556","volume":"278","author":"KP Patel","year":"2000","unstructured":"Patel KP, Zhang K, Carmines PK (2000) Norepinephrine turnover in peripheral tissues of rats with heart failure. Am J Physiol Regul Integr Comp Physiol 278: R556\u2013562","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"BF03040468_CR44","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1161\/01.CIR.94.4.690","volume":"94","author":"CR Benedict","year":"1996","unstructured":"Benedict CR, Shelton B, Johnstone DE, Francis G, Greenberg B, Konstam M, et al (1996) Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. SOLVD Investigators. Circulation 94: 690\u2013697","journal-title":"Circulation"},{"key":"BF03040468_CR45","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1748-1716.1994.tb09685.x","volume":"150","author":"QP Feng","year":"1994","unstructured":"Feng QP, Carlsson S, Thoren P, Hedner T (1994) Characteristics of renal sympathetic nerve activity in experimental congestive heart failure in the rat. Acta Physiol Scand 150: 259\u2013266","journal-title":"Acta Physiol Scand"},{"key":"BF03040468_CR46","first-page":"R27","volume":"266","author":"GF DiBona","year":"1994","unstructured":"DiBona GF, Sawin LL (1994) Reflex regulation of renal nerve activity in cardiac failure. Am J Physiol 266: R27\u201339","journal-title":"Am J Physiol"},{"key":"BF03040468_CR47","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1152\/physrev.1997.77.1.75","volume":"77","author":"GF DiBona","year":"1997","unstructured":"DiBona GF, Kopp UC (1997) Neural control of renal function. Physiol Rev 77: 75\u2013197","journal-title":"Physiol Rev"},{"key":"BF03040468_CR48","doi-asserted-by":"crossref","first-page":"H1247","DOI":"10.1152\/ajpcell.1998.275.5.C1247","volume":"275","author":"PF Mento","year":"1998","unstructured":"Mento PF, Pica ME, Hilepo J, Chang J, Hirsch L, Wilkes BM (1998) Increased expression of glomerular AT1 receptors in rats with myocardial infarction. Am J Physiol 275: H1247\u20131253","journal-title":"Am J Physiol"},{"key":"BF03040468_CR49","first-page":"R923","volume":"265","author":"KP Patel","year":"1993","unstructured":"Patel KP, Zhang PL, Krukoff TL (1993) Alterations in brain hexokinase activity associated with heart failure in rats. Am J Physiol 265 (4 Pt 2): R923\u2013928","journal-title":"Am J Physiol"},{"key":"BF03040468_CR50","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1161\/01.CIR.100.1.82","volume":"100","author":"GF DiBona","year":"1999","unstructured":"DiBona GF, Sawin LL (1999) Effect of metoprolol administration on renal sodium handling in experimental congestive heart failure. Circulation 100: 82\u201386","journal-title":"Circulation"},{"key":"BF03040468_CR51","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1055\/s-2007-1007296","volume":"14","author":"JH Henriksen","year":"1994","unstructured":"Henriksen JH, Ring-Larsen H (1994) Hepatorenal disorders: role of the sympathetic nervous system. Semin Liver Dis 14: 35\u201343","journal-title":"Semin Liver Dis"},{"key":"BF03040468_CR52","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1161\/01.RES.56.3.457","volume":"56","author":"KM Nicholls","year":"1985","unstructured":"Nicholls KM, Shapiro MD, Van Putten VJ, Kluge R, Chung HM, Bichet DG, et al (1985) Elevated plasma norepinephrine concentrations in decompensated cirrhosis. Association with increased secretion rates, normal clearance rates, and suppressibility by central blood volume expansion. Circ Res 56: 457\u2013461","journal-title":"Circ Res"},{"key":"BF03040468_CR53","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1056\/NEJM198212163072504","volume":"307","author":"DG Bichet","year":"1982","unstructured":"Bichet DG, Van Putten VJ, Schrier RW (1982) Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis. N Engl J Med 307: 1552\u20131557","journal-title":"N Engl J Med"},{"key":"BF03040468_CR54","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/0168-8278(91)90810-X","volume":"13","author":"C Gaudin","year":"1991","unstructured":"Gaudin C, Braillon A, Poo JL, Moreau R, Hadengue A, Lebrec D (1991) Regional sympathetic activity, severity of liver disease and hemodynamics in patients with cirrhosis. J Hepatol 13: 161\u2013168","journal-title":"J Hepatol"},{"key":"BF03040468_CR55","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/j.1475-097X.1981.tb00898.x","volume":"1","author":"JH Henriksen","year":"1981","unstructured":"Henriksen JH, Christensen NJ, Ring-Larsen H (1981) Noradrenaline and adrenaline concentrations in various vascular beds in patients with cirrhosis. Relation to haemodynamics. Clin Physiol 1: 293\u2013304","journal-title":"Clin Physiol"},{"key":"BF03040468_CR56","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/j.1475-097X.1988.tb00265.x","volume":"8","author":"JH Henriksen","year":"1988","unstructured":"Henriksen JH, Ring-Larsen H, Christensen NJ (1988) Kidney, lower limb and whole-body uptake and release of catecholamines in alcoholic liver disease. Clin Physiol 8: 203\u2013213","journal-title":"Clin Physiol"},{"key":"BF03040468_CR57","first-page":"R390","volume":"238","author":"DR Kostreva","year":"1980","unstructured":"Kostreva DR, Castaner A, Kampine JP (1980) Reflex effects of hepatic baroreceptors on renal and cardiac sympathetic nerve activity. Am J Physiol 238: R390\u2013394","journal-title":"Am J Physiol"},{"key":"BF03040468_CR58","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0168-8278(87)80569-X","volume":"5","author":"JA Solis-Herruzo","year":"1987","unstructured":"Solis-Herruzo JA, Duran A, Favela V, Castellano G, Madrid JL, Munoz-Yague MT, et al (1987) Effects of lumbar sympathetic block on kidney function in cirrhotic patients with hepatorenal syndrome. J Hepatol 5: 167\u2013173","journal-title":"J Hepatol"},{"key":"BF03040468_CR59","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1056\/NEJM199108293250905","volume":"325","author":"IT Meredith","year":"1991","unstructured":"Meredith IT, Broughton A, Jennings GL, Esler MD (1991) Evidence of a selective increase in cardiac sympathetic activity in patients with sustained ventricular arrhythmias. N Engl J Med 325: 618\u2013624","journal-title":"N Engl J Med"},{"key":"BF03040468_CR60","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1046\/j.1523-1755.1999.00391.x","volume":"55","author":"AK Bleyer","year":"1999","unstructured":"Bleyer AK, Russell GB, Satko SG (1999) Sudden and cardiac death rates in hemodialysis patients. Kidney Int 55: 1553\u20131559","journal-title":"Kidney Int"},{"key":"BF03040468_CR61","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1001\/jama.259.13.1976","volume":"259","author":"J Wikstrand","year":"1988","unstructured":"Wikstrand J, Warnold I, Olsson G, Tuomilehto J, Elmfeldt D, Berglund G (1988) Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY study. JAMA 259: 1976\u20131982","journal-title":"JAMA"},{"key":"BF03040468_CR62","doi-asserted-by":"crossref","unstructured":"(1985) Cardiovascular risk and risk factors in a randomized trial of treatment based on the beta-blocker oxprenolol: the International Prospective Primary Prevention Study in Hypertension (IPPPSH). The IPPPSH Collaborative Group. J Hypertens 3: 379\u2013392","DOI":"10.1097\/00004872-198508000-00011"},{"key":"BF03040468_CR63","doi-asserted-by":"crossref","unstructured":"(1997) Management of stable angina pectoris. Recommendations of the Task Force of the European Society of Cardiology. Eur Heart J 18: 394\u2013413","DOI":"10.1093\/oxfordjournals.eurheartj.a015259"},{"key":"BF03040468_CR64","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1136\/bmj.318.7200.1730","volume":"318","author":"N Freemantle","year":"1999","unstructured":"Freemantle N, Cleland J, Young P, Mason J, Harrison J (1999) Beta blockade after myocardial infarction: systematic review and meta regression analysis. BMJ 318: 1730\u20131737","journal-title":"BMJ"},{"key":"BF03040468_CR65","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1056\/NEJM199808203390801","volume":"339","author":"SS Gottlieb","year":"1998","unstructured":"Gottlieb SS, McCarter RJ, Vogel RA (1998) Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med 339: 489\u2013497","journal-title":"N Engl J Med"},{"key":"BF03040468_CR66","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S0140-6736(00)02606-4","volume":"356","author":"PA Rochon","year":"2000","unstructured":"Rochon PA, Tu JV, Anderson GM, Gurwitz JH, Clark JP, Lau P, et al (2000) Rate of heart failure and 1-year survival for older people receiving low-dose beta-blocker therapy after myocardial infarction. Lancet 356: 639\u2013644","journal-title":"Lancet"},{"key":"BF03040468_CR67","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/BF02374508","volume":"36","author":"M Koch","year":"1993","unstructured":"Koch M, Thomas B, Tschope W, Ritz E (1993) Survival and predictors of death in dialysed diabetic patients. Diabetologia 36: 1113\u20131117","journal-title":"Diabetologia"},{"key":"BF03040468_CR68","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1046\/j.1523-1755.1999.00359.x","volume":"55","author":"R Agarwal","year":"1999","unstructured":"Agarwal R (1999) Supervised atenolol therapy in the management of hemodialysis hypertension. Kidney Int 55: 1528\u20131535","journal-title":"Kidney Int"},{"key":"BF03040468_CR69","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","volume":"334","author":"M Packer","year":"1996","unstructured":"Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, et al (1996) The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med 334: 1349\u20131355","journal-title":"N Engl J Med"},{"key":"BF03040468_CR70","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1053\/ajkd.2001.29259","volume":"38","author":"MW Taal","year":"2001","unstructured":"Taal MW, Brenner BM (2001) Achieving maximal renal protection in nondiabetic chronic renal disease. Am J Kidney Dis 38: 1365\u20131371","journal-title":"Am J Kidney Dis"},{"key":"BF03040468_CR71","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1001\/jama.288.19.2421","volume":"288","author":"JT Wright","year":"2002","unstructured":"Wright JT Jr, Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J, et al (2002) Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA 288: 2421\u20132431","journal-title":"JAMA"},{"key":"BF03040468_CR72","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1097\/01.ASN.0000045049.72965.B7","volume":"14","author":"IH Klein","year":"2003","unstructured":"Klein IH, Ligtenberg G, Oey PL, Koomans HA, Blankestijn PJ (2003) Enalapril and losartan reduce sympathetic hyperactivity in patients with chronic renal failure. J Am Soc Nephrol 14: 425\u2013430","journal-title":"J Am Soc Nephrol"},{"key":"BF03040468_CR73","first-page":"1857","volume":"24","author":"R Luccioni","year":"1995","unstructured":"Luccioni R (1995) Pharmaco-epidemiologic evaluation of rilmenidine in 18, 235 hypertensive patients. Presse Med 24: 1857\u20131864","journal-title":"Presse Med"},{"key":"BF03040468_CR74","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0022-3565(25)21405-7","volume":"230","author":"P Bousquet","year":"1984","unstructured":"Bousquet P, Feldman J, Schwartz J (1984) Central cardiovascular effects of alpha adrenergic drugs: differences between catecholamines and imidazolines. J Pharmacol Exp Ther 230: 232\u2013236","journal-title":"J Pharmacol Exp Ther"},{"key":"BF03040468_CR75","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/204748730000700110","volume":"7","author":"B Bauduceau","year":"2000","unstructured":"Bauduceau B, Mayaudon H, Dupuy O (2000) Rilmenidine in the hypertensive type-2 diabetic: a controlled pilot study versus captopril. J Cardiovasc Risk 7: 57\u201361","journal-title":"J Cardiovasc Risk"},{"key":"BF03040468_CR76","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/BF03040436","volume":"115","author":"H Puttinger","year":"2003","unstructured":"Puttinger H, Soleiman A, Oberbauer R (2003) Regression of hypertensive nephropathy during three years of optimal blood pressure control. Wien Klin Wochenschr 115: 429\u2013431","journal-title":"Wien Klin Wochenschr"}],"container-title":["Wiener Klinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03040468.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF03040468\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03040468","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03040468.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T11:04:33Z","timestamp":1739099073000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF03040468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,9]]},"references-count":76,"journal-issue":{"issue":"17-18","published-print":{"date-parts":[[2003,9]]}},"alternative-id":["BF03040468"],"URL":"https:\/\/doi.org\/10.1007\/bf03040468","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"type":"print","value":"0043-5325"},{"type":"electronic","value":"1613-7671"}],"subject":[],"published":{"date-parts":[[2003,9]]},"article-number":"634"}}